[Catecholaminergic polymorphic ventricular tachycardia] (Q84985344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

title

[Catecholaminergic polymorphic ventricular tachycardia] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

catecholaminergic polymorphic ventricular tachycardia

13 February 2020

main subject

0 references

ventricular tachycardia

1 reference

G Frommeyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

C Pott

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

E Schulze-Bahr

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

L Eckardt

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

publication date

18 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

Herzschrittmachertherapie & Elektrophysiologie

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

231-236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.

13 February 2020

cites work

1 reference

12 December 2020

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

1 reference

12 December 2020

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia

1 reference

12 December 2020

Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia

1 reference

12 December 2020

Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice

1 reference

12 December 2020

[Totally subcutaneous cardioverter-defibrillator (S-ICD®) : recent experience and future perspectives]

1 reference

12 December 2020

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

1 reference

12 December 2020

Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond

1 reference

12 December 2020

Catecholaminergic polymorphic ventricular tachycardia

1 reference

12 December 2020

Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations

1 reference

12 December 2020

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

1 reference

12 December 2020

Prophylactic left thoracic sympathectomy to prevent electrical storms in CPVT patients needing ICD placement

1 reference

12 December 2020

Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature

1 reference

12 December 2020

Clinical experiences of patients with catecholaminergic polymorphic ventricular tachycardia

1 reference

12 December 2020

Inhibition of cardiac Ca2 release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.

1 reference

12 December 2020

Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients

1 reference

12 December 2020

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

1 reference

12 December 2020

L-type calcium channels

1 reference

12 December 2020

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

1 reference

12 December 2020

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia

1 reference

12 December 2020

Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human

1 reference

12 December 2020

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

1 reference

12 December 2020

High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening

1 reference

12 December 2020

Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol

1 reference

12 December 2020

Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers.

1 reference

12 December 2020

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death

1 reference

12 December 2020

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia

1 reference

12 December 2020

Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments

1 reference

12 December 2020

Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing

1 reference

12 December 2020

[Arrhythmic storm induced by AICD discharge in a patient with catecholaminergic polymorphic ventricular tachycardia]

1 reference

12 December 2020

10.1007/S00399-012-0224-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22987135 AND SRC:MED&resulttype=core&format=json

13 February 2020

1 reference